Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
Working-age adults with Parkinson’s disease who received deep brain stimulation (DBS) showed better social and occupational functioning than those who received the best medical therapies alone, a study has ... Read more
Researchers have developed a highly sensitive but low-cost method to detect dopamine, which may help in the early diagnosis of several disorders characterized by abnormal dopamine levels such as ... Read more
A direct causal link was found between two major underlying features of Parkinson’s disease — mitochondrial defects and lysosomal malfunction — in dopamine producing neurons that lacked the PARK2 ... Read more
With a single treatment, scientists were able to transform brain cells into functioning neurons that restored dopamine — the signaling molecule deficient in people with Parkinson’s disease — to ... Read more
An oxygen-free (anaerobic) formulation of dopamine infused directly into the brain of monkeys with induced Parkinson’s safely improved both their motor and cognitive symptoms, according to a new study. These findings ... Read more
An important signaling pathway that helps protect brain cells from neurodegenerative diseases such as Parkinson’s disease is also required for sleep in fruit flies and zebrafish, according to a ... Read more